These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29747856)

  • 1. Paradoxical Decision-Making: A Framework for Understanding Cognition in Parkinson's Disease.
    Perugini A; Ditterich J; Shaikh AG; Knowlton BJ; Basso MA
    Trends Neurosci; 2018 Aug; 41(8):512-525. PubMed ID: 29747856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptual decisions based on previously learned information are independent of dopaminergic tone.
    Perugini A; Basso MA
    J Neurophysiol; 2018 Mar; 119(3):849-861. PubMed ID: 29167328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with Parkinson's Disease Show Impaired Use of Priors in Conditions of Sensory Uncertainty.
    Perugini A; Ditterich J; Basso MA
    Curr Biol; 2016 Jul; 26(14):1902-10. PubMed ID: 27322000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reward Pays the Cost of Noise Reduction in Motor and Cognitive Control.
    Manohar SG; Chong TT; Apps MA; Batla A; Stamelou M; Jarman PR; Bhatia KP; Husain M
    Curr Biol; 2015 Jun; 25(13):1707-16. PubMed ID: 26096975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision-making impairments in Parkinson's disease as a by-product of defective cost-benefit analysis and feedback processing.
    Ryterska A; Jahanshahi M; Osman M
    Neurodegener Dis Manag; 2014; 4(4):317-27. PubMed ID: 25313988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease.
    Zhang J; Rittman T; Nombela C; Fois A; Coyle-Gilchrist I; Barker RA; Hughes LE; Rowe JB
    Brain; 2016 Jan; 139(Pt 1):161-73. PubMed ID: 26582559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are people with Parkinson's disease really impaired on when it comes to making decisions? A meta-analysis of the evidence.
    Ryterska A; Jahanshahi M; Osman M
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2836-46. PubMed ID: 24157725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding decision-making deficits in neurological conditions: insights from models of natural action selection.
    Frank MJ; Scheres A; Sherman SJ
    Philos Trans R Soc Lond B Biol Sci; 2007 Sep; 362(1485):1641-54. PubMed ID: 17428775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual Hallucinations Are Characterized by Impaired Sensory Evidence Accumulation: Insights From Hierarchical Drift Diffusion Modeling in Parkinson's Disease.
    O'Callaghan C; Hall JM; Tomassini A; Muller AJ; Walpola IC; Moustafa AA; Shine JM; Lewis SJG
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Nov; 2(8):680-688. PubMed ID: 29560902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
    Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
    Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocomputational models of motor and cognitive deficits in Parkinson's disease.
    Wiecki TV; Frank MJ
    Prog Brain Res; 2010; 183():275-97. PubMed ID: 20696325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of subthalamic nucleus stimulation and levodopa on decision-making in Parkinson's disease.
    Atkinson-Clement C; Cavazzini É; Zénon A; Witjas T; Fluchère F; Azulay JP; Baunez C; Eusebio A
    Mov Disord; 2019 Mar; 34(3):377-385. PubMed ID: 30681186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic influences on risk preferences of Parkinson's disease patients.
    Kobayashi S; Asano K; Matsuda N; Ugawa Y
    Cogn Affect Behav Neurosci; 2019 Feb; 19(1):88-97. PubMed ID: 30306414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval timing and Parkinson's disease: heterogeneity in temporal performance.
    Merchant H; Luciana M; Hooper C; Majestic S; Tuite P
    Exp Brain Res; 2008 Jan; 184(2):233-48. PubMed ID: 17828600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of deep brain stimulation of the subthalamic nucleus on perceptual decision making.
    Zaehle T; Wagenbreth C; Voges J; Heinze HJ; Galazky I
    Neuroscience; 2017 Feb; 343():140-146. PubMed ID: 27956065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensorimotor subthalamic stimulation restores risk-reward trade-off in Parkinson's disease.
    Irmen F; Horn A; Meder D; Neumann WJ; Plettig P; Schneider GH; Siebner HR; Kühn AA
    Mov Disord; 2019 Mar; 34(3):366-376. PubMed ID: 30485537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-Dependent Loss Aversion during Effort-Based Decision-Making.
    Chen X; Voets S; Jenkinson N; Galea JM
    J Neurosci; 2020 Jan; 40(3):661-670. PubMed ID: 31727795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Biologically Plausible Action Selection System for Cognitive Architectures: Implications of Basal Ganglia Anatomy for Learning and Decision-Making Models.
    Stocco A
    Cogn Sci; 2018 Mar; 42(2):457-490. PubMed ID: 28585747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality Traits and Cortical Activity Affect Gambling Behavior in Parkinson's Disease.
    Balconi M; Siri C; Meucci N; Pezzoli G; Angioletti L
    J Parkinsons Dis; 2018; 8(2):341-352. PubMed ID: 29614700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.